September has historically ranked among the more challenging months for the Australian share market — a pattern often associated with the period following the August reporting season, when attention turns to offshore catalysts and portfolio rebalancing — yet not every stock moves in step with the broader index.

In this week's analysis, Wealth Within senior analysts Filip Tortevski and Pedro Banales examine three ASX-listed stocks that have historically performed strongly during September and, notably, carry potential catalysts that could support them again in 2026.

Paladin Energy (ASX: PDN)

The first stock highlighted is uranium producer Paladin Energy, whose key asset is the Langer Heinrich mine in Namibia. The company heads into September on the back of a strong FY26 result, with production coming in at the top end of its guidance range and costs at the lower end. Elevated uranium prices, combined with growing global interest in energy security and nuclear power — including renewed commitments to nuclear capacity in several countries — provide additional tailwinds for the producer.

Fisher & Paykel Healthcare (ASX: FPH)

The second pick is Fisher & Paykel Healthcare, a New Zealand-based designer and manufacturer of respiratory care products used in hospitals and home care. The healthcare sector can offer defensive characteristics during volatile markets, as demand for medical products tends to be less tied to economic cycles, and Fisher & Paykel has upgraded its FY27 outlook following stronger demand for its hospital hardware and consumables. The stock's recent breakout to record highs also places it firmly on investors' radar.

Orica (ASX: ORI)

Finally, Orica — one of the world's largest suppliers of commercial explosives and blasting technology to the mining industry — could benefit from continued strength in global gold and copper mining activity, which in turn supports demand for its mining products and technology. Elevated commodity prices have generally encouraged mining activity, which feeds directly into Orica's order book.

The analysts note that seasonality alone is never sufficient to justify an investment. Instead, Filip and Pedro combine historical performance data, current fundamentals and technical analysis to assess whether these three stocks could outperform this September. Investors will be watching upcoming commodity price movements and company-level developments as the month unfolds.

The material provided in this article is for information only and should not be treated as investment advice. Readers are encouraged to conduct their own research and consult a certified financial advisor before making any investment decisions.